Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Pimicotinib

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Merck, AstraZeneca Announce Phase 3 Win for Cancer Drug
    Merck, AstraZeneca Announce Phase 3 Win for Cancer Drug

    12 Nov 2024

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/merck-kgaas-phase-3-rare-tumor-trial-hits-goal-teeing-rivalry-daiichi-and-ono?itm_source=parsely-api

    FIERCE BIOTECH
    12 Nov 2024
    Share Share
    Merck KGaA plans China submission after win for tumor drug
    Merck KGaA plans China submission after win for tumor drug

    12 Nov 2024

    // ENDPTS

    https://endpts.com/merck-kgaa-plans-china-submission-after-late-stage-win-for-tumor-drug/

    ENDPTS
    12 Nov 2024
    Share Share
    Pimicotinib Shows Improved Outcomes in Ph 3 Trial for Tenosynovial Tumor
    Pimicotinib Shows Improved Outcomes in Ph 3 Trial for Tenosynovial Tumor

    11 Nov 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/pimicotinib-significantly-improved-outcomes-for-patients-with-tenosynovial-giant-cell-tumor-in-a-global-phase-iii-trial-302301539.html

    PR NEWSWIRE
    11 Nov 2024
    Share Share
    Abbisko announces that EMA has granted orphan drug designation forPimicotinib
    Abbisko announces that EMA has granted orphan drug designation forPimicotinib

    08 Jan 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/abbisko-therapeutic-announces-that-ema-has-granted-orphan-drug-designation-for-its-csf-1r-inhibitor-pimicotinib-absk021-302028394.html

    PR NEWSWIRE
    08 Jan 2024
    Share Share
    Abbisko Announces that FDA Has Granted Fast Track Designation for Pimicotinib
    Abbisko Announces that FDA Has Granted Fast Track Designation for Pimicotinib

    13 Dec 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/abbisko-therapeutics-announces-that-us-fda-has-granted-fast-track-designation-for-its-csf-1r-inhibitor-pimicotinib-absk021-302014220.html

    PR NEWSWIRE
    13 Dec 2023
    Share Share
    Merck KGaA, Darmstadt, Germany Strengthens Oncology Portfolio
    Merck KGaA, Darmstadt, Germany Strengthens Oncology Portfolio

    04 Dec 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231129696616/en

    BUSINESSWIRE
    04 Dec 2023
    Share Share